Turn Therapeutics Inc. (TTRX) P/E Ratio History
Historical price-to-earnings valuation from 2026 to 2026
Loading P/E history...
TTRX Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our TTRX DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
TTRX P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $109B | 28.1 | 3.39 | +837%Best | |
| $74B | 17.2 | 2.72 | +8% | |
| $356B | 85.0 | - | -1% | |
| $2B | 6.9Lowest | 0.67Best | +817% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
See TTRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TTRX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TTRX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTTRX — Frequently Asked Questions
Quick answers to the most common questions about buying TTRX stock.
Is TTRX stock overvalued or undervalued?
TTRX current P/E: N/A. 5-year average P/E: N/A. Percentile: N/A.
How does TTRX's valuation compare to peers?
Turn Therapeutics Inc. P/E of N/A compares to sector median of 22.2x. Sector comparison provides relative valuation context.
What is TTRX's PEG ratio?
TTRX PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2026-2026.